›Delayed primary closure option after 48 to 72 hours if clean
›Advanced wound management
›Deep wounds in hand, foot fascial compartments, or truncal wounds
›Operating room exploration required
›Not suitable for bedside management
›Negative pressure wound therapy for large necrotic wounds
›Freshwater stingray wounds may require prolonged healing
›NPWT supports wound healing in case series
›Stepwise analgesia
›Hot water immersion first-line
›Non-pharmacologic and highly effective
›NSAIDs for mild residual pain
›Ibuprofen 400 to 600 mg PO every 6 to 8 hours
›Ketorolac 15 to 30 mg IV for parenteral option
›Opioids for severe pain
›Morphine 0.1 mg/kg IV titrated to effect
›Fentanyl 1 mcg/kg IV for rapid onset
›Local and regional anesthesia
›Local infiltration with 1 to 2% lidocaine without epinephrine
›Regional nerve block with 0.5% bupivacaine for larger wounds
›Digital nerve block for digit injuries
›Prophylactic antibiotics
›Recommended for high contamination risk of marine puncture wounds
›Deep punctures
›Large wounds
›Immunocompromised patients
›Wounds in high-risk anatomic locations
›Saltwater injury regimens
›Ciprofloxacin 500 mg PO twice daily for 5 to 7 days
›Doxycycline 100 mg PO twice daily for 5 to 7 days
›Cover Vibrio and marine gram-negative organisms
›Freshwater injury regimens
›Ciprofloxacin 500 mg PO twice daily
›Levofloxacin 500 mg PO daily
›Third-generation cephalosporin alternative
›Antibiotic avoidance
›First-generation cephalosporins inadequate Vibrio coverage
›Penicillin inadequate Vibrio coverage
›Ampicillin inadequate Vibrio coverage
›Erythromycin alone inadequate Vibrio coverage
›Treatment of established infection
›Parenteral regimen for serious infection
›Ceftazidime 2 g IV every 8 hours plus doxycycline 100 mg IV every 12 hours
›Fluoroquinolone IV as alternative
›Carbapenem for severe or resistant Vibrio sepsis
›Vibrio sepsis
›Combination therapy recommended
›Duration guided by clinical response
›Infectious disease consultation
›Tetanus wound management
›Marine puncture wounds are tetanus-prone wounds
›Deep puncture
›Contaminated wound
›Tetanus toxoid if not current
›Update if greater than 5 years since booster for tetanus-prone wound
›Tetanus immunoglobulin if unvaccinated or unknown status
›250 units IM with concurrent toxoid at separate site
›Do not apply to wound site
›Ineffective or harmful interventions
›Cryotherapy or ice
›Vasoconstriction worsens tissue damage
›Topical steroids
›No benefit demonstrated
›Antihistamines
›Not indicated for acute envenomation
›Meat tenderizer
›No evidence of efficacy
›Ammonia application
›No evidence of efficacy
›Potassium permanganate
›Caustic and harmful to wound